Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: An in vivo microdialysis study
Yt. Fu et al., Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: An in vivo microdialysis study, J NEUROSC, 21(22), 2001, pp. 8979-8989
Norepinephrine (NE) secretion within the hypothalamic paraventricular nucle
us (PVN) is pivotal to endocrine and behavioral responses. Activation of NE
afferents to PVN also is necessary for the hypothalamo-pituitary-adrenal a
xis response to passively administered nicotine. The mode of drug delivery
is a critical determinant of the dynamics of neurotransmitter secretion, ye
t the PVN NE response to nicotine self-administration (SA) is unknown. Here
in, rats housed in operant chambers had unlimited 23 hr access to self-admi
nistered nicotine. In vivo microdialysis of PVN NE was performed, collectin
g consecutive 7 min samples over 9 hr sessions during three phases of nicot
ine SA: acquisition (day 1); early maintenance, once stable rates of SA wer
e achieved (day 9.2 +/- 0.6); later maintenance (day 18.6 +/- 0.8). On d1,
nicotine animals had an increased percentage of SA episodes (SAEs) in which
NE levels were elevated (80 vs 30% with saline; p < 0.01). By early mainte
nance, a fourfold increase in such episodes was observed in nicotine animal
s (p < 0.01), and the overall NE level was greater (1.30 +/- 0.24 vs 0.63 /- 0.07 pg/10 mul in saline; p < 0.05); NE increased during the first, but
not the last, SAE. The pattern was similar during later maintenance, althou
gh NE responsiveness declined (overall NE level, 0.96 +/- 0.19 in nicotine
vs 0.52 +/- 0.08 pg/10 <mu>l in saline; p < 0.05). Therefore, nicotine SAEs
were associated with sustained increases in NE secretion during all three
phases of SA. However, the reduced NE responsiveness observed both within t
he dialysis session in each phase and by later versus early maintenance is
consistent with progression of partial daily desensitization of PVN NE secr
etion to nicotine SA. Therefore, in rats chronically self-administering nic
otine, the drug stimulates sustained PVN NE secretion that may alter neuroe
ndocrine and behavioral responses mediated by the PVN. Compared with studie
s of chronic human smokers, our nicotine SA model may reflect the CNS norad
renergic responses that occur during human cigarette smoking.